Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
A suspicious account made a 35x profit on a pump-and-dump scheme, buying 2 hours before on the belief that the Suez Canal would reopen.

A suspicious account made a 35x profit on a pump-and-dump scheme, buying 2 hours before on the belief that the Suez Canal would reopen.

BlockBeatsBlockBeats2026/04/09 08:05

According to PolyBeats monitoring, on the Polymarket prediction market, 1 account has placed a $10.0k bet on "Is the Suez Canal back to normal transit this month?" with the current "Yes" probability at 26.5%.

This account previously profited $475.6k (+3,503%) by betting on "US-Iran ceasefire by April 7th" when the probability was below 3%.

Note: Based on their trading history, this trader does not necessarily believe in the actual outcome of events and may engage in profit-taking or stop-loss behavior at certain points after opening a position.

Account:
0xd7375270e4769d3cc31885773070a5f12d5bbe95

Total Investment: $10.0k
---------------------------------
See tomorrow, today. Follow @PolyBeatsEN for early access to future events.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.